Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,303 | 3,936 | $4.2M | $1.9M |
| 2022 | 24 | 3,213 | 3,672 | $4.1M | $1.9M |
| 2021 | 20 | 2,643 | 3,103 | $3.8M | $1.7M |
| 2020 | 19 | 2,483 | 2,843 | $3.1M | $1.3M |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 776 | 862 | $3.0M | $1.3M | 43.6% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 179 | 187 | $655,424 | $288,890 | 44.1% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 953 | 1,053 | $78,975 | $63,264 | 80.1% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Office | 2023 | 187 | 201 | $90,651 | $51,233 | 56.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 65 | 66 | $99,000 | $26,879 | 27.2% |
| 78264 | Nuclear medicine study of stomach to assess emptying | Office | 2023 | 74 | 75 | $33,390 | $21,808 | 65.3% |
| 78227 | Nuclear medicine study of liver and bile duct system with use of drugs | Office | 2023 | 52 | 52 | $50,627 | $19,940 | 39.4% |
| 78315 | Nuclear medicine study of bone taken at different times | Office | 2023 | 65 | 66 | $32,670 | $19,780 | 60.5% |
| 78708 | Nuclear medicine study of kidney, blood, flow, and function with drug administration | Office | 2023 | 49 | 58 | $31,900 | $9,462 | 29.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 55 | 224 | $14,415 | $9,355 | 64.9% |
| 78071 | Nuclear medicine study of parathyroid with spect | Office | 2023 | 27 | 27 | $21,549 | $8,403 | 39.0% |
| 78226 | Nuclear medicine study of liver and bile duct system | Office | 2023 | 28 | 28 | $19,446 | $7,778 | 40.0% |
| 78014 | Nuclear medicine study of thyroid and thyroid function | Office | 2023 | 36 | 36 | $19,400 | $7,690 | 39.6% |
| A9562 | Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | Office | 2023 | 25 | 31 | $10,090 | $7,269 | 72.0% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 107 | 173 | $7,788 | $6,047 | 77.6% |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | Office | 2023 | 73 | 74 | $6,793 | $5,451 | 80.2% |
| J2805 | Injection, sincalide, 5 micrograms | Office | 2023 | 50 | 50 | $6,603 | $4,958 | 75.1% |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | Office | 2023 | 257 | 272 | $5,632 | $4,424 | 78.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 67 | 68 | $22,440 | $3,769 | 16.8% |
| 78070 | Nuclear medicine study of parathyroid | Office | 2023 | 14 | 14 | $7,469 | $3,764 | 50.4% |
| A9512 | Technetium tc-99m pertechnetate, diagnostic, per millicurie | Office | 2023 | 24 | 175 | $3,500 | $2,808 | 80.2% |
| A9539 | Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries | Office | 2023 | 28 | 32 | $3,170 | $2,506 | 79.1% |
| A9516 | Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries | Office | 2023 | 35 | 35 | $2,805 | $2,251 | 80.2% |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | Office | 2023 | 77 | 77 | $2,773 | $2,224 | 80.2% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 691 | 784 | $2.7M | $1.2M | 44.8% |
About Dr. Lisa Kalimi, MD
Dr. Lisa Kalimi, MD is a Diagnostic Radiology healthcare provider based in Lindenhurst, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780654772.
As a Medicare-enrolled provider, Kalimi has provided services to 11,642 Medicare beneficiaries, totaling 13,554 services with total Medicare billing of $6.8M. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Lindenhurst, NY
- Active Since 01/24/2006
- Last Updated 10/27/2009
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1780654772
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Lindenhurst
Alan Melton, Md, MD
Diagnostic Radiology — Payments: $59,449
Suzanne Smith, Md, MD
Diagnostic Radiology — Payments: $58,483
Steven Mendelsohn, Md, MD
Diagnostic Radiology — Payments: $22,397
David Dorfman, Md, MD
Diagnostic Radiology — Payments: $4,070
Karin Ohlig, Md, MD
Diagnostic Radiology — Payments: $3,899
Dr. Rebecca Obedian, Md, MD
Diagnostic Radiology — Payments: $1,669